Kjetil Taskén

17.2k total citations · 2 hit papers
288 papers, 13.2k citations indexed

About

Kjetil Taskén is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Kjetil Taskén has authored 288 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Molecular Biology, 104 papers in Immunology and 52 papers in Oncology. Recurrent topics in Kjetil Taskén's work include Immune Cell Function and Interaction (63 papers), T-cell and B-cell Immunology (55 papers) and Protein Kinase Regulation and GTPase Signaling (33 papers). Kjetil Taskén is often cited by papers focused on Immune Cell Function and Interaction (63 papers), T-cell and B-cell Immunology (55 papers) and Protein Kinase Regulation and GTPase Signaling (33 papers). Kjetil Taskén collaborates with scholars based in Norway, United States and Germany. Kjetil Taskén's co-authors include Einar Martin Aandahl, Tomas Mustelin, Vidar Hansson, Knut Martin Torgersen, Torkel Vang, Tore Jahnsen, Bjørn Steen Skålhegg, Sheraz Yaqub, John D. Scott and Milada Mahic and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kjetil Taskén

285 papers receiving 13.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A

2004 619 citations Kjetil Taskén, Einar Martin Aandahl profile →
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant

2005 534 citations Kjetil Taskén et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kjetil Taskén	7.4k	4.1k	2.1k	1.2k	1.1k	288	13.2k
Bing Su	11.0k 1.5×	5.6k 1.4×	2.7k 1.3×	1.2k 1.0×	1.1k 1.0×	178	17.7k
Roy A. Black	7.3k 1.0×	3.9k 1.0×	3.8k 1.8×	873 0.7×	1.4k 1.3×	95	14.8k
Tucker Collins	6.0k 0.8×	4.0k 1.0×	1.5k 0.7×	851 0.7×	1.2k 1.1×	86	12.4k
Patrick Matthias	9.3k 1.2×	3.4k 0.8×	2.4k 1.2×	1.7k 1.4×	611 0.6×	109	13.6k
Masahide Asano	4.8k 0.7×	3.8k 0.9×	1.4k 0.7×	820 0.7×	847 0.8×	169	11.0k
Matthias Gaestel	11.6k 1.6×	3.4k 0.8×	2.4k 1.1×	785 0.6×	1.5k 1.4×	259	16.7k
Michael Leitges	7.2k 1.0×	3.0k 0.7×	1.5k 0.7×	733 0.6×	1.3k 1.2×	237	12.7k
Curt Milliman	9.6k 1.3×	2.4k 0.6×	2.8k 1.4×	654 0.5×	744 0.7×	9	14.1k
Jeremy Saklatvala	6.9k 0.9×	3.6k 0.9×	2.8k 1.3×	823 0.7×	795 0.7×	154	14.0k
Claus Scheidereit	7.6k 1.0×	5.3k 1.3×	2.9k 1.4×	1.5k 1.2×	515 0.5×	103	14.3k

Countries citing papers authored by Kjetil Taskén

Since Specialization

Citations

This map shows the geographic impact of Kjetil Taskén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjetil Taskén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjetil Taskén more than expected).

Fields of papers citing papers by Kjetil Taskén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjetil Taskén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjetil Taskén. The network helps show where Kjetil Taskén may publish in the future.

Co-authorship network of co-authors of Kjetil Taskén

This figure shows the co-authorship network connecting the top 25 collaborators of Kjetil Taskén. A scholar is included among the top collaborators of Kjetil Taskén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjetil Taskén. Kjetil Taskén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Våtsveen, Thea Kristin, Andrej Bešše, Sigrid S. Skånland, et al.. (2025). Targeting proteostasis in multiple myeloma through inhibition of LTK. Leukemia. 39(9). 2237–2245. 1 indexed citations

Gelderblom, Hans, Anders Edsjö, Ulrik Lassen, et al.. (2023). 1711P The DRUP-like clinical trials family: A distributed European trial network for equitable access to precision medicine. Annals of Oncology. 34. S933–S934. 1 indexed citations

Gordon, Sandra, Heikki Kuusanmäki, Kjetil Taskén, et al.. (2023). Standardized assays to monitor drug sensitivity in hematologic cancers. Cell Death Discovery. 9(1). 435–435. 11 indexed citations

Tveita, Anders, et al.. (2023). A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine. Cell Death Discovery. 9(1). 125–125. 10 indexed citations

Raj, Deepak B. Thimiri Govinda, Sigrid S. Skånland, Geir E. Tjønnfjord, et al.. (2022). Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically. Molecular Oncology. 16(6). 1241–1258. 14 indexed citations

Flobak, Åsmund, Sigrid S. Skånland, Eivind Hovig, Kjetil Taskén, & Hege G. Russnes. (2022). Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models. Trends in Pharmacological Sciences. 43(11). 973–985. 9 indexed citations

Fernandes, Stacey M., Alberto J. Arribas, Kjetil Taskén, et al.. (2022). Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 28(20). 4444–4455. 11 indexed citations

Jenum, Synne, Kristian Tonby, Corina S. Rueegg, et al.. (2021). A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nature Communications. 12(1). 6774–6774. 50 indexed citations

Holien, Toril, Jorrit M. Enserink, Jennifer R. Brown, et al.. (2021). Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies. Molecular Oncology. 16(5). 1153–1170. 13 indexed citations

10.

Giansanti, Piero, Enio Gjerga, Aurélien Dugourd, et al.. (2021). Systems approach reveals distinct and shared signaling networks of the four PGE ₂ receptors in T cells. Science Signaling. 14(703). eabc8579–eabc8579. 6 indexed citations

11.

Jiang, Xiaojun, Annika Bergquist, Britt-Sabina Löscher, et al.. (2021). A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis. Science Translational Medicine. 13(582). 15 indexed citations

12.

Haug, Markus, Marianne Sandvold Beckwith, Claire Louet, et al.. (2020). Sensing of HIV-1 by TLR8 activates human T cells and reverses latency. Nature Communications. 11(1). 147–147. 66 indexed citations

13.

Skånland, Sigrid S., et al.. (2020). B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia. Scandinavian Journal of Immunology. 92(5). e12931–e12931. 18 indexed citations

14.

Skånland, Sigrid S., et al.. (2019). An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL. Leukemia. 34(2). 478–487. 25 indexed citations

15.

Skånland, Sigrid S. & Kjetil Taskén. (2019). Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling. The Journal of Immunology. 203(4). 1055–1063. 7 indexed citations

16.

Gerbaud, Pascale, et al.. (2017). Ezrin-anchored PKA phosphorylates serine 369 and 373 on connexin 43 to enhance gap junction assembly, communication, and cell fusion. Biochemical Journal. 475(2). 455–476. 19 indexed citations

17.

Ellinger, Bernhard, Anjali Prashar, Johannes Landskron, et al.. (2014). A Phenotypic Screening Approach to Identify Anticancer Compounds Derived from Marine Fungi. Assay and Drug Development Technologies. 12(3). 162–175. 6 indexed citations

18.

Pettersen, Frank Olav, Anders Erik Astrup Dahm, Ingeborg S. Aaberge, et al.. (2011). An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses. Journal of Virology. 85(13). 6557–6566. 53 indexed citations

19.

Bjørgo, Elisa, Hilde Abrahamsen, George S. Baillie, et al.. (2010). Cross Talk between Phosphatidylinositol 3-Kinase and Cyclic AMP (cAMP)-Protein Kinase A Signaling Pathways at the Level of a Protein Kinase B/β-Arrestin/cAMP Phosphodiesterase 4 Complex. Molecular and Cellular Biology. 30(7). 1660–1672. 57 indexed citations

20.

Grønning, Line M., Maria K. Dahle, Kristin A. Taskén, et al.. (1999). Isoform-Specific Regulation of the CCAAT/Enhancer-Binding Protein Family of Transcription Factors by 3′,5′-Cyclic Adenosine Monophosphate in Sertoli Cells*. Endocrinology. 140(2). 835–843. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact